About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

NCT00901979·67 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Novartis Pharmaceuticals

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

HbA1c from 7.0-10.0%, Stable Metformin dose

You may not be if

CHF Class III-IV, Liver disease

The record

StatusCompleted

PhasePhase 2

Taking part693

StartedApr 2009

UpdatedJan 9, 2013

Conditions

Type 2 Diabetes Mellitus

Where67

Clinical Research Advantage
Mesa, Arizona, United States
Mesa Family Medical Center/Clinical Research Advantage
Mesa, Arizona, United States
Woodland International Reserach Group, LLC
Little Rock, Arkansas, United States

Clareo Health | A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)